JP2013241476A5 - - Google Patents

Download PDF

Info

Publication number
JP2013241476A5
JP2013241476A5 JP2013188248A JP2013188248A JP2013241476A5 JP 2013241476 A5 JP2013241476 A5 JP 2013241476A5 JP 2013188248 A JP2013188248 A JP 2013188248A JP 2013188248 A JP2013188248 A JP 2013188248A JP 2013241476 A5 JP2013241476 A5 JP 2013241476A5
Authority
JP
Japan
Prior art keywords
topiramate
sodium
solid preparation
crystals
carmellose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013188248A
Other languages
English (en)
Japanese (ja)
Other versions
JP6125957B2 (ja
JP2013241476A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013188248A priority Critical patent/JP6125957B2/ja
Priority claimed from JP2013188248A external-priority patent/JP6125957B2/ja
Publication of JP2013241476A publication Critical patent/JP2013241476A/ja
Publication of JP2013241476A5 publication Critical patent/JP2013241476A5/ja
Application granted granted Critical
Publication of JP6125957B2 publication Critical patent/JP6125957B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013188248A 2007-04-12 2013-09-11 トピラマート含有固形製剤 Active JP6125957B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013188248A JP6125957B2 (ja) 2007-04-12 2013-09-11 トピラマート含有固形製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007104853 2007-04-12
JP2007104853 2007-04-12
JP2013188248A JP6125957B2 (ja) 2007-04-12 2013-09-11 トピラマート含有固形製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008103209A Division JP5424571B2 (ja) 2007-04-12 2008-04-11 トピラマート含有固形製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016207609A Division JP2017014289A (ja) 2007-04-12 2016-10-24 トピラマート含有固形製剤

Publications (3)

Publication Number Publication Date
JP2013241476A JP2013241476A (ja) 2013-12-05
JP2013241476A5 true JP2013241476A5 (ru) 2014-02-13
JP6125957B2 JP6125957B2 (ja) 2017-05-10

Family

ID=40141447

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008103209A Active JP5424571B2 (ja) 2007-04-12 2008-04-11 トピラマート含有固形製剤
JP2013188248A Active JP6125957B2 (ja) 2007-04-12 2013-09-11 トピラマート含有固形製剤
JP2016207609A Pending JP2017014289A (ja) 2007-04-12 2016-10-24 トピラマート含有固形製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008103209A Active JP5424571B2 (ja) 2007-04-12 2008-04-11 トピラマート含有固形製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016207609A Pending JP2017014289A (ja) 2007-04-12 2016-10-24 トピラマート含有固形製剤

Country Status (1)

Country Link
JP (3) JP5424571B2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
KR101931209B1 (ko) 2010-05-11 2018-12-20 얀센 파마슈티카 엔.브이. Sglt의 억제제로서 1-(베타-d-글루코피라노실)-2-티에닐-메틸벤젠 유도체를 포함하는 약학 제형
AU2012241897C1 (en) 2011-04-13 2017-05-11 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of SGLT2
IN2013MU02470A (ru) * 2013-07-25 2015-06-26 Cadila Healthcare Ltd
CN108379588A (zh) * 2018-03-05 2018-08-10 合肥合源药业有限公司 托吡酯组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
UA65607C2 (ru) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтическая композиция (варианты) и способ ее приготовления
EP1157682A1 (en) * 2000-05-25 2001-11-28 Cilag AG Blister package for topiramate tablets
DE10153078A1 (de) * 2001-10-30 2003-05-22 Degussa Verwendung von Granulaten auf Basis von pyrogen hergestelltem Siliciumdioxid in pharmazeutischen Zusammensetzungen
EP1587499A1 (en) * 2003-01-31 2005-10-26 Elan Pharma International Limited Nanoparticulate topiramate formulations
EP1701708A2 (en) * 2003-12-29 2006-09-20 Alza Corporation Novel drug compositions and dosage forms of topiramate
EP1973528B1 (en) * 2006-11-17 2012-11-07 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
WO2008070670A2 (en) * 2006-12-04 2008-06-12 Supernus Pharmaceuticals, Inc. Enhanced immediate release formulations of topiramate

Similar Documents

Publication Publication Date Title
JP2013241476A5 (ru)
JP2014533655A5 (ru)
HK1211579A1 (en) Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl- cyano-methyl)-amides inhibitors of athepsin 2--[221]-3-(--)-
MX2015016070A (es) Composiciones antitranspirantes.
WO2014070928A3 (en) Sodium hypochlorite composition
HRP20151263T1 (hr) Natrijeva sol 6-fluoro-3-hidroksi-2-pirazinkarboksamida
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
PH12014000291A1 (en) Tobacco product wrapping material with controlled burning properties
CA2647492A1 (en) Stabilization of milk of lime suspensions
JO3229B1 (ar) العمل على استقرار الهرمون المنبه للجريب
RU2012110758A (ru) Способ получения сахарсодержащего продукта
JP2015500014A5 (ru)
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
RU2014143976A (ru) Таблетки, содержащие 5-гидрокси-1н-имидазол-4-карбоксамид
MX354454B (es) Procedimiento de elaboracion de microcapsulas entericas de alginato por gelacion ionica que contienen diclofenac o una de sus sales y composicion farmaceutica multiparticulada que las contiene.
EA201291022A1 (ru) Твердая фармацевтическая композиция для нейтрализации желудочной кислоты
MX2015000023A (es) Profármacos novedosos de rebamipida, metodo preparación y su uso.
HRP20211524T1 (hr) Sol derivata cefalosporina, kristalni kruti oblik istog i postupak za njegovu proizvodnju
JP2016074851A5 (ru)
RU2016125712A (ru) ФАРМАЦЕВТИЧЕСКИЙ КОМБИНИРОВАННЫЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ ИНГИБИТОР HMG-СоА РЕДУКТАЗЫ И ИНГИБИТОР АБСОРБЦИИ ХОЛЕСТЕРИНА
RU2013151914A (ru) Способ получения глинозема
RU2017140923A (ru) Стабилизированная фармацевтическая композиция
EA201591945A1 (ru) Пищевой солевой продукт
EA201591090A1 (ru) Способ изготовления минеральной соли и продукта на основе минеральной соли
RU2010150469A (ru) Способ получения ангидрата и гидратов динатриевой соли кремниевой кислоты (метасиликата натрия) безводных, пятиводных, шестиводных, девятиводных